Hospital
Troy Community Hospital Incorporated
Troy Community Hospital Incorporated was paid $1.10M by Medicaid between Oct 2019 and Nov 2024, across 78 billing codes. Its largest line is 99283, emergency room visit (moderate) — 36% of everything it billed.
33Billing provider infoTROY COMMUNITY HOSPITAL INCORPORATED
TROY, PA 16947
TROY, PA 16947
33aNPI1306847926assigned 08/04/2005
33bProvider typeCritical Access Hospital
28Total paid$1.10M
24GClaims37,859
24DCodes billed78
24AFirst – last monthOct 2019 – Nov 2024
Compared with peers
Next to other Critical Access Hospital providers in Pennsylvania
Rank by total paid#8 of 12
Median peer was paid$1.19M
This provider vs. median0.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 56 | $88.77 | |
| 2020 | 6,610 | $98K | |
| 2021 | 19,601 | $495K | |
| 2022 | 4,206 | $142K | |
| 2023 | 4,659 | $226K | |
| 2024incomplete | 2,727 | $144K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 36% | 4,582 | 3,746 | $393K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 1,833 | 1,572 | $202K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 13% | 1,843 | 1,748 | $147K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 4.2% | 239 | 235 | $47K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.8% | 341 | 298 | $42K |
| 80053 | Comprehensive metabolic panel | 3.2% | 3,817 | 3,308 | $36K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.7% | 706 | 674 | $29K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.6% | 3,623 | 3,117 | $17K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.3% | 271 | 241 | $14K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1.1% | 170 | 167 | $12K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 345 | 317 | $11K |
| 80050 | General health panel | <1% | 186 | 186 | $10K |
66 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 742 | $10K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 830 | $9K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 479 | $8K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 116 | $8K |
| T1015 | A visit at a community health center or clinic (one all-in rate) | <1% | 232 | $8K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,049 | $7K |
| 83880 | <1% | 297 | $6K | |
| 84484 | <1% | 983 | $6K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 143 | $5K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 346 | $5K |
| 80061 | Lipid panel | <1% | 352 | $5K |
| 87040 | <1% | 411 | $4K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 201 | $4K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 26 | $4K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 41 | $3K |
| 83690 | <1% | 733 | $3K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 139 | $3K |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,223 | $3K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 51 | $2K |
| 83605 | <1% | 636 | $2K | |
| 71045 | Radiologic examination, chest; single view | <1% | 392 | $2K |
| 85610 | <1% | 847 | $2K | |
| 85730 | <1% | 480 | $2K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 412 | $2K |
| 84703 | <1% | 192 | $2K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 809 | $2K |
| 73564 | <1% | 90 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 388 | $2K |
| 82150 | <1% | 409 | $2K | |
| 85378 | <1% | 196 | $1K | |
| 81003 | <1% | 596 | $1K | |
| 83735 | <1% | 251 | $1K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 90 | $1K |
| 76830 | Ultrasound, transvaginal | <1% | 24 | $1K |
| 73630 | <1% | 116 | $1K | |
| 72110 | <1% | 60 | $1K | |
| 84439 | <1% | 141 | $1K | |
| 73610 | <1% | 51 | $1K | |
| 87807 | <1% | 63 | $998.06 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 199 | $974.22 |
| 85651 | <1% | 344 | $923.24 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 29 | $897.53 |
| 81001 | <1% | 361 | $797.94 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 110 | $765.14 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 14 | $748.27 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 51 | $674.20 |
| 82607 | <1% | 59 | $667.09 | |
| 87081 | <1% | 110 | $631.71 | |
| 85027 | <1% | 51 | $460.83 | |
| 82746 | <1% | 43 | $454.56 | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 12 | $393.35 |
| 86618 | <1% | 13 | $376.62 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 14 | $364.30 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 94 | $347.10 |
| 73030 | <1% | 14 | $237.98 | |
| 81025 | <1% | 44 | $197.56 | |
| 73130 | <1% | 14 | $178.04 | |
| 86140 | <1% | 59 | $175.32 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,065 | $144.89 |
| 83540 | <1% | 12 | $123.99 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,050 | $73.49 |
| 83550 | <1% | 12 | $73.32 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 14 | $15.83 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 0% | 443 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 23 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMACAFEE, FRANCIS (VP CFO FINANCE)
| Provider | Location | Paid |
|---|---|---|
| Corning Hospital | Corning, NY | $17.73M |
| Robert Packer Hospital | Sayre, PA | $13.81M |
| Robert Packer Hospital | Towanda, PA | $1.93M |
| Robert Packer Hospital | Towanda, PA | $816K |
| Guthrie Towanda Memorial Hospital | Towanda, PA | $192K |
| Robert Packer Hospital | Sayre, PA | $11K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.